Searched for
WOCKHARDT PLANT
Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...- Wockhardt shuts US manufacturing plantThe company expects the US plant shutdown and transfer of products from inhouse to third-party contract manufacturers to help save $12 mill...
- USFDA issues warning letter to Wockhardt's Ankleshwar plantUSFDA has already banned import of products from the facility into the US market since August 5, 2016.
- Neutral Wockhardt Ltd., target Rs 1015.0 : Macquarie Capital SecuritiesMacquarie says expects stock to trade at discount to fair value of Rs 1,320 in the medium term as regulatory uncertainty prevails
- Wockhardt's Chikalthana plant gets GMP certificate from UKMHRAIn a major relief to drug firm Wockhardt, its Chikalthana plant at Aurangabad in Maharashtra has received a good manufacturing practice cer...
- UK MHRA completes inspection of Wockhardt's Chikalthana plantWockhardt said the UK health regulator has completed inspection of its plant at Chikalthana without issuing any critical observations on th...
- USFDA finds procedural lapses at Wockhardt's US facilityThe US Food and Drug Administration has found as many as 12 procedural lapses in drug maker Wockhardt's US facility in Illinois.
- Wockhardt recalls over 109,000 bottles of hypertension drug in USWockhardt Ltd is recalling 109,744 bottles of a high blood pressure drug in the US after it failed a dissolution test, the US Food and Drug...
- Why multibagger Wockhardt is on analysts' 'sell' radar nowFundamental troubles or the regulatory problems are not going to go away in a hurry for Wockhardt and it has become more of a trading stock...
- Wockhardt plunges 14% as USFDA issues import alert on Chikalthana PlantThe Chikalthana facility received ‘483’ observations after the USFDA raised several concerns. This is the second plant in India to get impo...
- Wockhardt may face £1 million hit due to Kadaiya unit lapsesWockhardt today said it will take a revenue hit of nearly one million pounds due to import restrictions imposed by the UK health regulator ...
- Another Wockhardt plant under MHRA scannerThis is the drug maker's second plant whose GMP certificate has been taken away by MHRA and the third to face regulatory heat this year.
- Wockhardt continues to slide as street loses faithOn July 18, the US FDA said in a warning letter that the company “repeatedly delayed, denied, limited an inspection or refused to permit th...
- Wockhardt skids 20% on US warning over manufacturing practicesShares in Mumbai-based drug maker Wockhardt plunged 20% on Wednesday after details emerged of a warning by the US Food and Drug Administrat...
- Wockhardt gets warning letter from USFDA over Waluj plantWockhardt said it has received a warning letter from US health regulator over its facility at Waluj in Maharashtra not meeting manufacturin...
- UK regulator MHRA recalls 16 drugs made at Wockhardt's Waluj plantMHRA today said it has issued a precautionary recall for sixteen medicines made by Wockhardt at its Waluj unit due to manufacturing shortco...
- Wockhardt allays investor fears on US 'import ban'USFDA had imposed a ban on imports from Wockhardt's Aurangabad factory in Maharashtra, citing quality concerns of drugs.
- Wockhardt gets USFDA approval to market generic ProtonixThe company will manufacture the generic tablets at its US Food and Drug Administration's certified plant at Waluj, Maharashtra.
- Wockhardt gets USFDA tentative nod for generic rhinitis drugPharmaceutical and biotechnology firm Wockhardt today said it has received tentative approval from USFDA to sell generic version of Sanofi ...
- Fire damages Wockhardt's unit at AnkleshwarA fire at pharmaceutical major Wockhardt’s Rs 300-crore Ankleshwar facility damaged one of its six manufacturing plants.
Load More- Neutral Wockhardt Ltd., target Rs 1015.0 : Macquarie Capital Securities
